Compare ARK Genomic Revolution ETF (ARKG) vs Bank of Nova Scotia (BNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Bank of Nova Scotia — how do they compare? ARK Genomic Revolution ETF trades at $44.88, while Bank of Nova Scotia trades at $89.03 (market cap $108.32B). The key difference: Bank of Nova Scotia pays a 3.64% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | BNS | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $44.55 | $90.29 |
52-Week Low | $24.02 | $56.41 |
Market Cap | — | $108.32B |
Dividend Yield | — | 3.64% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →
